When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Pfizer-OPKO's growth hormone drug gets US approval in kids - AOL

   www.aol.com/news/us-fda-approves-pfizers-drug...

   (Reuters) -The U.S. Food and Drug Administration has approved Pfizer Inc and partner OPKO Health Inc's treatment for growth hormone deficiency in children, the companies said on Wednesday. The ...

3. Opko Health (OPK) Q3 2024 Earnings Call Transcript - AOL

   www.aol.com/finance/opko-health-opk-q3-2024...

   Opko Health (NASDAQ: OPK) Q3 2024 Earnings Call Nov 07, 2024, 4:30 p.m. ET. Contents: ... The third sort of news is that we have parties that are interested in our platform to collaborate with us ...

4. OPKO Health (OPK) Loses 16.2% Despite In-Line Q3 Earnings - AOL

   www.aol.com/news/opko-health-opk-loses-16...

   OPKO Health's (OPK) third-quarter results benefit from increase in RAYALDEE prescriptions.

5. Opko Health (OPK) Q2 2024 Earnings Call Transcript - AOL

   www.aol.com/opko-health-opk-q2-2024-041521206.html

   Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q2 2024 Earnings Call Aug 07, 2024, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...

6. OPKO Health (OPK) Q3 Earnings Miss Estimates, Revenues Beat - AOL

   www.aol.com/news/opko-health-opk-q3-earnings...

   OPKO Health (OPK) third-quarter results benefit from higher Product revenues and RAYALDEE prescription growth.

7. Opko Launches Phase 2 Trial Of Covid Treatment Rayaldee ...

   www.aol.com/news/opko-launches-phase-2-trial...

   Opko Health announced the initiation of a Phase 2 trial of Rayaldee as a treatment for mild-to-moderate COVID-19. After rising in the pre-market trading hours, Opko stock was down 0.63% at the ...

8. OPKO Health (OPK) to Report Q3 Earnings: What's in Store? - AOL

   www.aol.com/news/opko-health-opk-report-q3...

   For premium support please call: 800-290-4726 more ways to reach us

9. OPKO Health (OPK) Stock Gains 2.1% Despite Q2 Earnings Miss - AOL

   www.aol.com/news/opko-health-opk-stock-gains...

   OPKO Health's (OPK) second-quarter results benefit from continued strength in its Pharmaceuticals segment. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ...